Chicago Arthritis's overview of GLP-1, CJC-1295, AOD-9604, and related peptides lists nausea, headaches, and fluid retention as possible side effects and stresses that any peptide plan, especially a combined or "stacked" protocol, needs to be built and monitored by a knowledgeable physician (chicagoarthritis.com)
Dry vial: looks fine COA: looks perfect Reconstituted with BAC: cloudy, flaking, unstable This isnt a rare edge case anymore This is starting to look less like coincidence and more like a repeat issue
Researchers observed that upon binding the IRR, ARA-290 initiates signaling through JAK2 and downstream pathways including STAT3 and NF-B modulation, distinct from the STAT5-dominant signaling of classical EPO receptor activation
the combination allows independent dose optimization